Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections

Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than intramuscular bivalent mRNA boosters.

Merz strengthens its global footprint with botulinum approval in Australian market – Pharmaceutical Technology

Share this article Xeomin along with common anti-wrinkle drug Botox (onabotulinumtoxinA) is also approved as a combination treatment for blepharospasm. Credit: ThiagoSantos/Shutterstock.com With approval granted

November 22, 2023

Regeneron accused by Justice Department of manipulating Medicare pricing

The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing by inflating the average sales price for its expensive and

April 11, 2024

First-Ever Biologic Approved for COPD

The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and Regeneron announced on Friday. An

September 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.